Hill-Rom Stock Forecast, Price & News

Hill-Rom (NYSE:HRC) Frequently Asked Questions

Is Hill-Rom a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Hill-Rom stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HRC, but not buy additional shares or sell existing shares.
View analyst ratings for Hill-Rom or view top-rated stocks.

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release its next quarterly earnings announcement on Friday, February 4th 2022.
View our earnings forecast for Hill-Rom.

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) issued its earnings results on Friday, November, 5th. The medical technology company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.20. The medical technology company had revenue of $797.90 million for the quarter, compared to analysts' expectations of $752.97 million. Hill-Rom had a trailing twelve-month return on equity of 23.07% and a net margin of 8.23%. The firm's revenue for the quarter was up 13.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.17 EPS.
View Hill-Rom's earnings history.

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom announced a quarterly dividend on Tuesday, November 2nd. Shareholders of record on Wednesday, December 15th will be paid a dividend of $0.24 per share on Friday, December 31st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date of this dividend is Tuesday, December 14th.
View Hill-Rom's dividend history.

Is Hill-Rom a good dividend stock?

Hill-Rom pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.62%. Hill-Rom has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Hill-Rom is 25.81%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Hill-Rom will have a dividend payout ratio of 13.37% next year. This indicates that Hill-Rom will be able to sustain or increase its dividend.
View Hill-Rom's dividend history.

What price target have analysts set for HRC?

6 brokers have issued 1 year target prices for Hill-Rom's stock. Their forecasts range from $122.00 to $156.00. On average, they anticipate Hill-Rom's share price to reach $144.00 in the next year. This suggests that the stock has a possible downside of 7.7%.
View analysts' price targets for Hill-Rom or view top-rated stocks among Wall Street analysts.

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the following people:

• John P. Groetelaars, President, Chief Executive Officer & Director
• Tim Lawrence, Senior Vice President-Operations
• Barbara W. Bodem, Chief Financial Officer & Senior Vice President
• Brian L. Lawrence, Chief Technology Officer & SVP-Innovation
• Ilana Shulman, Chief Compliance Officer

What is John P. Groetelaars' approval rating as Hill-Rom's CEO?

54 employees have rated Hill-Rom CEO John P. Groetelaars on Glassdoor.com. John P. Groetelaars has an approval rating of 82% among Hill-Rom's employees.

Who are some of Hill-Rom's key competitors?

Some companies that are related to Hill-Rom include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), Baxter International (BAX), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), STERIS (STE), Hologic (HOLX), Insulet (PODD) and Teleflex (TFX).
View all of HRC's competitors.

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), Square (SQ), PayPal (PYPL), salesforce.com (CRM), CVS Health (CVS), Micron Technology (MU), AbbVie (ABBV) and Bank of America (BAC).

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $155.96.

How much money does Hill-Rom make?

Hill-Rom has a market capitalization of $10.30 billion and generates $3.02 billion in revenue each year. The medical technology company earns $248.50 million in net income (profit) each year or $3.72 on an earnings per share basis.

How many employees does Hill-Rom have?

Hill-Rom employs 10,000 workers across the globe.

What is Hill-Rom's official website?

The official website for Hill-Rom is www.hill-rom.com.

Where are Hill-Rom's headquarters?

Hill-Rom is headquartered at 130 East Randolph Street Suite 1000, Chicago IL, 60601.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at (312) 819-7200, via email at [email protected], or via fax at 812-934-8189.